Relationship of smoking cessation period with the incidence of complications in lung cancer surgery.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 08 2022
Historique:
received: 10 09 2021
revised: 15 02 2022
accepted: 20 02 2022
pubmed: 11 3 2022
medline: 23 9 2022
entrez: 10 3 2022
Statut: ppublish

Résumé

The incidence of postoperative complications is relatively high in smokers. Although 4-week smoking cessation before surgery is generally recommended, it has not been sufficiently studied in lung cancer surgery. This study investigated whether smoking cessation for a short period of time significantly reduced complications after lung cancer surgery. This was a retrospective, observational study that investigated the relationship between the smoking cessation period and the incidence of complications in lung cancer surgery. Patients who underwent curative-intent surgery for lung cancer at our institution between January 2014 and December 2017 were included. The smokers were classified into the following 4 categories of smoking cessation period before surgery: current (<4 weeks), recent (4 weeks to 12 months), distant (12 months to 5 years) and ex-smokers (>5 years). A total of 911 patients were included in this study. The incidence of pulmonary complications was 5 times higher in the smoker group than in the never smoker group (12.9% vs 2.5%, P < 0.001). On multivariable analysis in both models, the odds ratio for complications was significantly higher in distant smokers than in recent smokers and never smokers. Across all models, low lung function significantly predicted the development of postoperative complications. The evidence-based smoking cessation duration that reduces the incidence of complications after thoracic surgery remains unclear. The incidence of postoperative complications was more strongly affected by low pulmonary function than by the duration of preoperative smoking cessation. For patients with marginal indications for surgery, postponing surgery to accommodate a smoking cessation period seemed unnecessary.

Identifiants

pubmed: 35266529
pii: 6546233
doi: 10.1093/ejcts/ezac163
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Yuka Kadomatsu (Y)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tomoshi Sugiyama (T)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Keiyu Sato (K)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Keita Nakanishi (K)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Harushi Ueno (H)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masaki Goto (M)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naoki Ozeki (N)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shota Nakamura (S)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Koichi Fukumoto (K)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toyofumi Fengshi Chen-Yoshikawa (TF)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH